|
PDIA3P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.018400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082040E-01 |
| Normal-vs-Stage2 |
2.958400E-01 |
| Normal-vs-Stage3 |
3.222600E-01 |
| Normal-vs-Stage4 |
9.176400E-01 |
| Stage1-vs-Stage2 |
9.970000E-01 |
| Stage1-vs-Stage3 |
1.163600E-01 |
| Stage1-vs-Stage4 |
4.808400E-01 |
| Stage2-vs-Stage3 |
1.463960E-01 |
| Stage2-vs-Stage4 |
4.493600E-01 |
| Stage3-vs-Stage4 |
4.710400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.721000E-01 |
| Normal-vs-AfricanAmerican |
7.909000E-01 |
| Normal-vs-Asian |
3.430800E-01 |
| Caucasian-vs-AfricanAmerican |
5.990000E-01 |
| Caucasian-vs-Asian |
2.840800E-01 |
| AfricanAmerican-vs-Asian |
3.253200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.091900E-02 |
| Normal-vs-Female |
4.248000E-02 |
| Male-vs-Female |
3.437700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.236600E-01 |
| Normal-vs-Extreme_Weight |
1.506370E-01 |
| Normal-vs-Obese |
1.619350E-01 |
| Normal-vs-Extreme_Obese |
1.486980E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.109600E-01 |
| Normal_Weight-vs-Obese |
4.605200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.453200E-01 |
| Extreme_Weight-vs-Obese |
9.367400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.747600E-01 |
| Obese-vs-Extreme_Obese |
2.833000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.243600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.456200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.272190E-01 |
| Normal-vs-Age(81-100Yrs) |
5.098600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.100800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.321800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.263200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.311600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.691800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.522000E-02 |
| Normal-VS-Type2 PRCC |
7.555000E-01 |
| Normal-VS-KIRP CIMP |
1.905580E-01 |
| Normal-VS-Unclassified PRCC |
7.389000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.237600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.224800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.416800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.372000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.832600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.731800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.714020E-01 |
| Normal-vs-N1 |
3.226400E-01 |
| Normal-vs-N2 |
3.953800E-01 |
| N0-vs-N1 |
1.470600E-01 |
| N0-vs-N2 |
7.978000E-02 |
| N1-vs-N2 |
8.556400E-01 |
|
|
